NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Stem Cell Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Stem Cell Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Graft-versus-Host Disease



Endothelial cell-derived microparticles elevated in acute graft-versus-host disease



August 14th, 2006

Endothelial cell-derived microparticle levels are elevated in acute graft-versus-host disease in allogeneic hematopoietic stem cell recipients.

According to a study from Germany, "Alterations of microparticles derived from different cell types are described in a number of diseases associated with inflammation and hemostatic disorders. In this prospective study, we firstly analyzed endothelial cell derived microparticles (EMP) in 19 hematopoietic stem cell recipients.

"Cultured human umbilical vein endothelial cells (HUVEC) stimulated with tumor necrosis factor-alpha (TNF-alpha) served as positive controls. EMP were analyzed by fluorescent activated...


Source: Stem Cell Week (2006-08-14)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login